Sai L. Shankar

Pomalidomide is effective for prevention and treatment of experimental skin fibrosis

Simon Weingärtner, Pawel Zerr, Michal Tomčík et al. · Annals of the Rheumatic Diseases · 2012 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study

Sibyl Wray, Florian Then Bergh, Annette Wundes et al. · Advances in Therapy · 2022 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

B. Singer, Douglas L. Arnold, Jelena Drulović et al. · Multiple Sclerosis Journal · 2023 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence

Jacob Liseno, Brittney Lager, Catherine Miller et al. · Neurology and Therapy · 2021 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis

Brittney Lager, Jacob Liseno, Ivan Božin et al. · Neurology and Therapy · 2022 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17